CRC ORE

CRC ORE is a Collaborative Research Centre focused on Optimising Resource Extraction in the Minerals Industry. Working with Mining companies, Mining Engineering, Technology and Services (METS) companies and Research organisations, our pinnacle technology developments are Grade Engineering and the Integrated Extraction Simulator. 
Grade Engineering is an approach focussed on early liberation of ore from waste working towards the ultimate vision of in-situ extraction. IES is a cllaborative multi-year program to build the next generation of metallurgical simulation platform.  
Ms Suzi Moore
Communications Coordinator 
Your interests
Communications
Ms Clytie Dangar
General Manager, Stakeholder Engagement 
Your interests

Effective Stakeholder Engagement.

Promoting long term Industry / Research collaboration

Commercialisation

Cluster development

Communications

CSIRO

Ms Sarah Spencer
Investment Portfolio Coordinator 
Your interests
CRC and CRC-Ps
Ms Christine Emmanuel
Executive Manager, Intellectual Property, Licence and Investment Portfolio 
Your interests

CSIRO, IP, licence and equity portfolios, CRC engagement

Mrs May Ling Goode
Investment Portfolio Coordinator 
Your interests
Business Development and Commercialisation, Equity Portfolio management.

CTx CRC Ltd

Cancer Therapeutics CRC (CTx) is in the business of finding cures for cancer. It was founded in 2007 and received an initial seven years of funding from the Cooperative Research Centre (CRC) Programme. It is a collaborative partnership of leading research institutes, universities and commercial enterprises that translates Australia’s innovative research discoveries into new cancer drugs ready for clinical development. 

Mr Brett Carter
Chief Operating Officer 
Your interests
Biotechnology
Dr Michelle Zajac
Director of Research & Alliance Management 
Your interests

Stakeholder Engagement, Collaborative partnerships, Communications, Government relations

Data61 | CSIRO

Ms Zoe Piper
Ms Zoe Piper
LinkedIn logo Partnerships Lead 
Your interests

As the Partnerships Lead for Data61 I'm responsible for developing a range of platforms designed to help connect researchers & industry. These include: Expert Connect (https://expertconnect.global/), Innovation Challenge marketplace (https://expertconnect.global/challenge/results) and InnovationMap (https://www.data61.csiro.au/Map). I'd be very interested to connect with anyone with relevant data (or who would like to make use of our data), and anyone who has an innovation challenge we might be able to help solve.

I also have a range of business interests that I'd be happy to connect with people about, including www.ecolour.com.au (non-toxic paint), and www.ethitrade.com.au (blockchain based provenance tracking for produce - currently working on tracking dragon fruit from Vietnam)

Deloitte

Dr Albert Canagasabey
Director | Global Investment and Innovation Incentives 
Your interests

I provide advice and assistance to companies in relation to government incentives available (R&D Tax Incentive and grants). My extensive scientific educational background and research (conducted at universities and CRCs) experience equips me with the necessary capability to provide sound advice in relation to the eligibility of R&D activities to the R&D Tax Incentive as well as grants.

Would appreciate an opportunity to meet CRC representatives to explore the possibility of partnering with them to assist their industry partners.

I am also open to meeting with companies to provide advice on government incentives that may be available to them.

Department of Industry, Innovation and Science

Mr Damien Ellwood
Assistant Manager Growth Centre Policy 
Your interests

Mark Weaver and Damien Ellwood work for the Department of Industry Innovation and Science in the Growth Centre Policy Section. We have policy responsibility for Growth Centres (including objectives around increasing collaboration and commercialisation; and improving access to global supply chains and international opportunities for industry), and we are on the secretariat for the University Precincts Advisory Committee.

We are interested in identifying and communicating industry need for research and innovation (e.g. through the Growth Centres' Industry Knowledge Priorities); in improving the links between industry and researchers (e.g. through innovation precincts); and in local and regional business and innovation networks focusing on export opportunities.

Mr Mark Weaver
Your interests

Mark Weaver and Damien Ellwood work for the Department of Industry Innovation and Science in the Growth Centre Policy Section. We have policy responsibility for Growth Centres (including objectives around increasing collaboration and commercialisation; and improving access to global supply chains and international opportunities for industry), and we are on the secretariat for the University Precincts Advisory Committee.

We are interested in identifying and communicating industry need for research and innovation (e.g. through the Growth Centres' Industry Knowledge Priorities); in improving the links between industry and researchers (e.g. through innovation precincts); and in local and regional business and innovation networks focusing on export opportunities.

Digital Health CRC

Mrs Elizabeth Foley
Establishment Manager 
Your interests
Health and Digital Technology
Mr David Jonas
CEO 
Your interests
Health and Digital Technology
Mrs Lee-Ann Breger
Head of Partner Relations and Program Officer 
Your interests
Health & Digital Technology

Domainex United Kingdom

Domainex is a fully integrated drug discovery service company based near Cambridge, UK serving pharmaceutical, biotechnology, academic and patient foundations globally.  Domainex’s drug discovery service business was established in 2001 and since that time has continued to expand to serve a wider range of clients across the world including Auspherix, UCB, FORMA Therapeutics, St George’s University and The Institute of Cancer Research.  Our expertise and commitment to providing high quality services has resulted in a strong success record in drug discovery, delivering an average one candidate drug every year for the past six years.

Domainex’s highly experienced molecular biologists, assay biologists, medicinal, computational and analytical chemists can be leveraged through our CRO services.  Domainex’s focus is on providing highly efficient and well considered scientific solutions to enable successful drug discovery programmes against a wide range of drug targets.  Whether your project is at an early stage of drug discovery or has already identified chemical matter, our processes have been shown to result in a 30% time-saving compared to industry standards and use less resource, allowing prudent management of your own budget.

Dr Tifelle Reisinger
Head of Business Development, Asia Pacific 
Your interests

Domainex offers a one-stop-shop service to meet all your drug discovery needs, from target to candidate. This includes:

- Domainex's platform technologies

- Combinatorial Domain Hunting (CDH)

- protein expression and purification

- biochemical assay development

- cell biology, including mode of action studies

- hit identification, using virtual or fragment-based approaches

- computational chemistry

- medicinal chemistry

- DMPK analysis

Domainex's focus is on providing a highly efficient and well considered scientific solution to enable successful drug discovery programmes against a wide range of drug targets (kinases, protein-protein interactions, GPCR, epigenetic, phenotypic...) in various therapeutic areas (oncology, anti-infectives, inflammation, cardiovascular diseases...).

I would be happy to discuss how Domainex can support your drug discovery programme.

DST Group

Mr Simon Martinovic
Deputy Director Strategic Engagement 
Your interests
I will be coming up from a meeting at Uni Wollongong and should be available to meet with people in the afternoon should they have any interest in understanding DST engagement models or collaborating with DST.
Dr Craig Rogers
A/Director Industry Engagement 
Your interests

DST Group is seeking opportunities to engage in collaborative research projects in the area of Defence. General areas in Defence we are looking to collaborate in include:

1. Sensors & hypersonics
2. Cyber
3. Medical Countermeasure
4. Quantum Technologies
5. Space Capabilities
6. Human Performance
7. Surveillance
8. Autonomous Systems
9. Material Sciences

As well as in our traditional domains of Maritime, Aerospace, Land.

Mr Jamie Watson
Innovator 
Your interests
Defence Research Innovation

ebilities

ebilities, the trading name of Lewis Cadman Consulting, is an Australian technology company who have designed, researched and developed an innovative range of online mental agility tests. These world leading tests are designed for use anywhere in the world to identify high potential candidates with the learning agility and problem solving skills needed for success in 21st century workplaces, and the confidence in their abilities to make timely decisions without the 'derailing' influence of overconfidence or underconfidence.

ebilities have constructed their short, sharp tests from the ground up for use in both established and emerging markets, for both small scale and mass recruitment. They are available in a number of languages, and can be taken on computers, tablets or mobile devices.

Mr Mark Cadman
Director 
Your interests

Our research interests surround the role of both mental agility and cognitive confidence in effective decision making.

Under conditions of uncertainty, a person’s mental agility is important because it underpins the formation of quick and accurate judgments, leading to better decision-making. But cognitive confidence is what turns ability into action. As a person’s cognitive confidence increases so does the likelihood that they will act decisively on their judgments. That’s good when people have the ability to back it up, and not so good when they don’t!

In employment settings, the most common finding in our research to date is that a lot of people tend to over-estimate their abilities. The upshot of this is that many people are overconfident and may systematically make sub-optimal decisions because they act on biased beliefs about their true abilities. Our research has also identified groups of higher ability people who tend to under-estimate their abilities, and who may be affected by the "Imposter Syndrome".

We have also undertaken studies under a TechVouchers grant into the interaction of mental agility and cognitive confidence in academic achievement of primary school children. The academic team we partnered with at the University of Newcastle here in NSW, have now had three papers published on the results of the research.